Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51

被引:10
|
作者
Diptee, M. D. [1 ]
Asgarali, Z. [1 ]
Campbell, M. [1 ]
Fosgate, G. [2 ]
Adesiyun, A. A. [1 ]
机构
[1] Univ W Indies, Sch Vet Med, Fac Med Sci, Fleurus, Trinidad Tobago
[2] Texas A&M Univ, Coll Vet Med, Dept Vet Internal Med, College Stn, TX 77843 USA
关键词
Brucella abortus RB51; Bubalus bubalis; challenge; vaccine; water buffalo;
D O I
10.20506/rst.26.3.1773
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Serological and bacteriological responses to Brucella abortus biovar 1 following vaccination with B. abortus strain RB51 (RB51) were evaluated in thirty domestic water buffalo (Bubalus bubalis) randomly divided into five treatment groups. Groups I to V received, respectively, the recommended dose (RD) of RB51 vaccine once, RD twice 4 weeks apart, double RD once, double RD twice 4 weeks apart, and saline once (control). Vaccination did not result in a serological response. Experimental animals released 27 weeks post initial inoculation (27 PIIW) into a brucellosis-positive herd failed to seroconvert after 29 weeks. Experimental challenge commenced at 57 PIIW. All animals received B. abortus biovar 1 intraconjunctivally at 0, 5 and 9 weeks post experimental exposure (PEEW). Serum samples collected at 4, 8 and 13 PEEW were negative. At 16 PEEW all animals received B. abortus biovar 1 subcutaneously (SC), and all seroconverted by 20 PEEW. Five of twenty-six animals were positive for Brucella infection on bacterial culture. Brucella abortus biovar 1 was isolated from three animals; B. abortus RB51 was isolated from two. Treatment group, age and sex had no effect on the isolation of Brucellae (P>0.05).
引用
收藏
页码:669 / 678
页数:10
相关论文
共 50 条
  • [21] Safety of Brucella abortus strain RB51 in bull elk
    Cook, WE
    Williams, ES
    Thorne, ET
    Kreeger, TJ
    Stout, GW
    Schurig, G
    Colby, LA
    Enright, F
    Elzer, PH
    JOURNAL OF WILDLIFE DISEASES, 2000, 36 (03) : 484 - 488
  • [22] Brucella abortus vaccine strain RB51: A brief review
    Schurig, G
    Boyle, S
    Sriranganathan, N
    ARCHIVOS DE MEDICINA VETERINARIA, 1995, 27 : 19 - 22
  • [23] Safety of Brucella abortus strain RB51 in black bears
    Olsen, SC
    Rhyan, J
    Gidlewski, T
    Goff, J
    Stoffregen, WC
    JOURNAL OF WILDLIFE DISEASES, 2004, 40 (03) : 429 - 433
  • [24] Selective media for isolation of Brucella abortus strain RB51
    Hornsby, RL
    Jensen, AE
    Olsen, SC
    Thoen, CO
    VETERINARY MICROBIOLOGY, 2000, 73 (01) : 51 - 60
  • [25] Safety of Brucella abortus strain RB51 in deer mice
    Cook, WE
    Williams, ES
    Thorne, ET
    Taylor, SK
    Anderson, S
    JOURNAL OF WILDLIFE DISEASES, 2001, 37 (03) : 621 - 625
  • [26] Oral vaccination of sexually mature pigs with Brucella abortus vaccine strain RB51
    Edmonds, MD
    Samartino, LE
    Hoyt, PG
    Hagius, SD
    Walker, JV
    Enright, FM
    Schurig, GG
    Elzer, P
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2001, 62 (08) : 1328 - 1331
  • [27] Biosafety of Brucella abortus strain RB51 for vaccination of mature bulls and pregnant heifers
    Edmonds, MD
    Schurig, GG
    Samartino, LE
    Hoyt, PG
    Walker, JV
    Hagius, SD
    Elzer, PH
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1999, 60 (06) : 722 - 725
  • [28] Biosafety and antibody responses of adult bison bulls after vaccination with Brucella abortus strain RB51
    Olsen, SC
    Rhyan, JC
    Gidlewski, T
    Palmer, MV
    Jones, AH
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1999, 60 (07) : 905 - 908
  • [29] Serologic responses of Brucella abortus strain 19 calfhood-vaccinated cattle following adult vaccination with strain RB51
    Olsen, SC
    Evans, D
    Hennager, SG
    Cheville, NF
    Stevens, MG
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 1996, 8 (04) : 451 - 454
  • [30] Immune Responses and Safety after Dart or Booster Vaccination of Bison with Brucella abortus Strain RB51
    Olsen, S. C.
    Johnson, C.
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (05) : 642 - 648